MTPConnect compiles a range of company reports, which provide an insight into our activities, funded projects and forward-looking sector trends.
FY2022 Annual Report
Our 2022 Annual Report is out now.
As Australia’s Growth Centre for the MTP sector, MTPConnect forges stronger connections between research and industry and maximises opportunities for Australians to make scientific and technological breakthroughs that are successfully translated and commercialised.
Across MTPConnect’s six strategic funding programs for DISR and the Medical Research Future Fund we have so far injected $141.2 million into Australia’s medical products sector, supporting 184 medical technology, biotechnology and pharmaceutical projects – with more funding to be deployed in coming years.
We’re also catalysing industry support to maximise the chances for commercialisation success, with our investments yielding $827 million in additional industry contributions and flow-on external investment.
Through our Researcher Exchange and Development within Industry (REDI) initiative, we are investing in training and skills programs to address key skills gaps in medical product development and commercialisation, with 20 partners and selected providers delivering a total of 46 programs with 380 events - providing 4,469 new training, mentoring and industry opportunities across Australia.
With funding allocated through our granting programs, the additional contributions provided by industry, the flow-on external investments and the money secured through grant reviews, MTPConnect has contributed to $1.3 billion flowing into Australia’s medical products sector.
It’s this critical mass of capital and productive collaboration between industry and research that will position Australia to commercialise the medical products coming out of the research in our universities and medical research institutes.
In recognition of our impact, the Government has approved an extended operation runway for MTPConnect. We have expanded our teams and with more funding to deploy we are set to build further on our activities in 2023 and beyond.
MTPConnect remains focused on supporting the science, research, innovation and entrepreneurship that underpins Australia’s vibrant medical products sector.
DOWNLOAD FY2021 ANNUAL REPORT DOWNLOAD FY2020 ANNUAL REPORT
FY2022 Business Plan
The FY2022 Business Plan from MTP-IIGC Ltd (trading name MTPConnect) is a contracted deliverable to the Department of Industry, Science, Energy and Resources (DISER).
Focusing on the four objectives of the Industry Growth Centre (IGC) Initiative - increasing Collaboration and Commercialisation, improving Management and Workforce Skills, optimising the Regulatory and Policy Environment and improving access to Global Supply Chains and Markets - MTPConnect forges stronger connections between research and industry and maximises opportunities for Australians to make scientific and technological breakthroughs that are successfully translated and commercialised.
In this way, we are building a more resilient and competitive medical products manufacturing sector.